Related Experiment Video
Updated: Dec 10, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective
Sai Krishna C Korada1, James A Mann2, Ayesha K Hasan2
1Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Insights
This case study details the initial management of a left ventricular assist device recipient with COVID-19. It highlights unique cardiac complications and clinical care over a 40-day disease course.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Devices
Background:
- COVID-19 presents significant risks to cardiovascular health, particularly for patients with pre-existing conditions.
- Left ventricular assist devices (LVADs) support patients with advanced heart failure.
- The intersection of COVID-19 and LVAD recipients presents unique clinical challenges.
Abstract:
COVID-19 is impacting the cardiovascular community both here in the United States and globally. The rapidly emerging cardiac complications have heightened implications for those with underlying cardiovascular disease. We describe an early case of COVID-19 in a left ventricular assist device recipient in the United States. We discuss our clinical management during the initial admission, outpatient management, and a unique complication of this disease over a 40-day disease course.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Mitral Stenosis IV: Nursing Management

